Cleared Traditional

K042721 - KOLIBRI SPINE

K042721 is an FDA 510(k) clearance for KOLIBRI SPINE, manufactured by Brainlab AG. The device is a Class 2 Neurology device with product code HAW cleared through the Traditional 510(k) pathway after a 200-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2005
Decision
200d
Days
Class 2
Risk

K042721 is an FDA 510(k) clearance for the KOLIBRI SPINE. Classified as Neurological Stereotaxic Instrument (product code HAW), Class II - Special Controls.

Submitted by Brainlab AG (Heimstetten, DE). The FDA issued a Cleared decision on April 19, 2005 after a review of 200 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.4560 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Brainlab AG devices

FDA 510(k) Submission Details - K042721

510(k) Number K042721 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 01, 2004
Decision Date April 19, 2005
Days to Decision 200 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
52d slower than avg
Panel avg: 148d · This submission: 200d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

HAW Device Classification - Class 2, Special Controls

Product Code HAW Neurological Stereotaxic Instrument
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.4560
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - HAW Neurological Stereotaxic Instrument

All 242
Devices cleared under the same product code (HAW) and FDA review panel - the closest regulatory comparables to K042721.
MODIFICATION TO: VOYAGER LINUX
K050973 · Mako Surgical Corp. · May 2005
AESCULAP ORTHOPILOT 2 THA V 2.0
K050752 · Aesculap, Inc. · Apr 2005
STRYKER NAVIGATION SYSTEM - CT-BASED HIP MODULE, MODEL 6007-621-000
K050615 · Stryker Instruments · Apr 2005
DEPUY CAS KNEE INSTRUMENTATION
K043223 · DePuy Orthopaedics, Inc. · Mar 2005
VECTORVISION OSTEOTOMY
K042513 · Brainlab AG · Feb 2005
VECTORVISION ACL
K042512 · Brainlab AG · Jan 2005